Coronary Disease Clinical Trials

Myocardial Ischemia and Transfusion (MINT)

View Myocardial Ischemia and Transfusion (MINT) information

The purpose of this study is to assess among patients with an acute myocardial infarction and a hemoglobin concentration less than 10 g/dL, if a liberal transfusion strategy with a threshold of 10 g/dL reduces the rate of the composite outcome of all-cause mortality or recurrent nonfatal acute myocardial infarction through 30 days following randomization compared to a restrictive transfusion strategy with a threshold of 7 to 8 g/dL.

Primary Investigator: Michael Gitter, MD
Subinvestigators: Matthew Karafin, MD; Nicole Lohr, MD, PhD; David S. Marks, MD, MBA

Status: Currently enrolling
Sub Category: General Cardiology

Meet Our Team


Michael J. Gitter, MD, FACC

Associate Professor


Nicole Lohr, MD, PhD, FACC

Associate Professor, Medical Director Cardiovascular Clinical Trials


David S. Marks, MD, MBA

Professor of Medicine and Radiology, Vice Chair for Clinical Affairs, Froedtert Hospital Senior Medical Director - Inpatient

Cardiovascular Clinical Trials

The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.

Please contact the Cardiovascular Trials program by calling (414) 955-7021 or at